The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Oberson Abels Ltd

20 RUE DE-CANDOLLE, 1205 GENEVA, SWITZERLAND
Tel:
Work +41 58 258 88 88
Fax:
Fax +41 58 258 88 89
Web:
www.obersonabels.com
Geneva, Lausanne, Neuchatel, Sion

 

The firm

Oberson Abels is a Swiss boutique focusing on tax, corporate/M&A and banking and financial services law. The tax team offers bespoke advice to individuals (including estate planning, structuring of compensation packages or advice to expatriates) and corporations (particularly regarding transactions and complex cross-border set-ups). The tax team also assists clients in their steps before courts and administrative authorities. Several partners teach tax or commercial law at Swiss universities. The firm’s banking and finance team provides comprehensive advice on the ever-growing field of financial regulation. The corporate/M&A team provides sophisticated advice in the fields of corporate and contract law (including in areas such as private equity, venture capital or regulated industries).

Areas of practice

Personal tax: taxation of income and wealth of individuals; employee benefit plans; pension plans and insurance; social security taxes; taxation of trusts; taxation of artists and athletes; matrimonial and estate planning; gift and estate taxes; relocation planning; residence and work permits.

Corporate tax: taxation of income and equity of corporations; mergers and acquisitions; reorganisations; taxation of international organisations and not-for-profit organisations; withholding tax; stamp tax. Industry-specific tax advice in diverse fields including banking, hedge funds, trading and IT services; bespoke tax advice for multinational groups.

Consumption/transaction taxes: VAT; customs/consumption taxes.

International/intercantonal taxation: international taxation including such fields as double tax treaties, BEPS, exchange of information, mutual agreement procedure, transfer pricing; assistance to Swiss taxpayers investing outside Switzerland; assistance to foreign taxpayers investing in Switzerland; intercantonal taxation.

Special fields of taxation: real estate taxation and property taxes; taxation of investment funds and of financial products; venture capital taxation; taxation of intellectual property; local taxes; environmental taxes.

Assistance in tax matters and disputes: preparation and negotiation of tax rulings; compliance; assistance in tax audits; tax litigation; criminal law assistance (especially for alleged tax, social security and customs fraud); voluntary disclosures. Preparation of tax returns and accessory tax filings (including VAT returns).

Corporate/M&A/project finance: advice on corporate law, from set-up to liquidation; M&A transactions in various industries (eg banking, biotech, IT, luxury goods, hotels, etc); project finance transactions, particularly in the field of renewable energy; joint ventures; assistance in investment rounds.

Restructuring of distressed companies: advice to companies in complex turnaround situations; advice to distressed companies, including tenure of the position of curator with companies which have applied for a moratorium.

Contracts/commercial: advice on contracts in all fields including sales, leases, licensing, employment, etc. Coverage includes special industries such as biotech, IT, luxury goods and hotels.

Banking and finance/regulatory matters: advice on financial services and products; licensing of banks, securities dealers and other regulated entities; negotiation of derivative agreements under the ISDA Master Agreement and the Swiss Master Agreement; drafting of netting and collateral opinions; advice on regulatory matters with regard to insurance and pension funds.

Investment funds: advice on all types of collective investment schemes; registration of Swiss and foreign funds; licensing of asset managers of Swiss collective investment schemes.

Capital markets: advice on stock exchange matters; public tender offers; issuance and listing of securities on the SIX Swiss Exchange including structured products and exchange traded funds (ETFs); disclosure of shareholdings and ad hoc publicity.

International organisations/not-for-profit organisations: advice to international organisations and not-for-profit organisations on their legal structure, status and governance, as well as on their global projects.

 

  • Other offices
  • Lausanne
  • Neuchâtel
  • Sion
  • Number of lawyers: 54
  • Languages
  • English
  • French
  • German
  • Spanish
  • Italian
  • Swiss German

Above material supplied by Oberson Abels Ltd.

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Awarded "Law Firm of the Year - Switzerland" at the Citywealth Magic Circle Awards 201

    Bär & Karrer is pleased to announce that it has received the award “Law Firm of the Year - Switzerland” at the Citywealth Magic Circle Awards in London. This award recognizes Bär & Karrer as the Swiss law firm with the best private client team.
  • Bär & Karrer Advises Ashcroft on the Acquisition of Rüeger Holding

    Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based Rüeger Holding SA (Rüeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc Rüeger.
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.